Sigma Healthcare Ltd (ASX: SIG) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Sigma Healthcare Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Sigma Healthcare Ltd (ASX: SIG)
Latest News

Capital Raising
Own Sigma shares? Everything you need to know about the 'transformational' $8.8b merger with Chemist Warehouse

Share Market News
5 things to watch on the ASX 200 on Monday

Healthcare Shares
Here's why I can't wait to buy Chemist Warehouse shares

Healthcare Shares
ASX 300 healthcare stock Sigma halted amid rumours of blockbuster Chemist Warehouse deal

Healthcare Shares
This ASX 300 stock just returned to profit, so why is its share price sinking?

Broker Notes
2 ASX 300 shares with 'continued upside': WAM

Share Fallers
Why Australian Ethical, Collins Foods, DGL, and Sigma shares are falling

Share Gainers
Why Boral, Imugene, Nickel Industries, and Sigma shares are rising today

Healthcare Shares
Is it too late to buy Sigma Healthcare shares following this week's 22% surge?

Broker Notes
3 ASX 300 shares just upgraded by top brokers

Share Fallers
Why ASX, Baby Bunting, Bowen Coking Coal, and EBOS shares are sinking today

Share Gainers
Why A2 Milk, Perenti, Sigma Healthcare, and Synlait shares are racing higher
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
25 Sep 2023 | $0.0050 | 100.00% | Interim | 11 Oct 2023 |
30 Mar 2023 | $0.0050 | 100.00% | Final | 18 Apr 2023 |
29 Sep 2022 | $0.0050 | 100.00% | Interim | 12 Oct 2022 |
04 Apr 2022 | $0.0100 | 100.00% | Final | 22 Apr 2022 |
24 Sep 2021 | $0.0100 | 100.00% | Interim | 08 Oct 2021 |
06 Apr 2021 | $0.0100 | 100.00% | Final | 21 Apr 2021 |
19 Sep 2019 | $0.0100 | 100.00% | Interim | 04 Oct 2019 |
03 Apr 2019 | $0.0200 | 100.00% | Final | 29 Apr 2019 |
12 Oct 2018 | $0.0150 | 100.00% | Interim | 29 Oct 2018 |
05 Apr 2018 | $0.0250 | 100.00% | Final | 20 Apr 2018 |
19 Sep 2017 | $0.0250 | 100.00% | Interim | 05 Oct 2017 |
06 Apr 2017 | $0.0300 | 100.00% | Final | 21 Apr 2017 |
20 Sep 2016 | $0.0250 | 100.00% | Interim | 03 Oct 2016 |
06 Apr 2016 | $0.0300 | 100.00% | Final | 21 Apr 2016 |
03 Apr 2014 | $0.0200 | 100.00% | Final | 30 Apr 2014 |
21 Sep 2012 | $0.0200 | 100.00% | Interim | 26 Oct 2012 |
05 Apr 2011 | $0.1500 | 100.00% | Special Cash | 11 May 2011 |
16 Oct 2009 | $0.0300 | 100.00% | Interim | 13 Nov 2009 |
31 Mar 2009 | $0.0400 | 100.00% | Final | 07 May 2009 |
30 Sep 2008 | $0.0300 | 100.00% | Interim | 29 Oct 2008 |
29 Aug 2005 | $0.0200 | 100.00% | Interim | 15 Sep 2005 |
02 Mar 2004 | $0.2000 | 100.00% | Final | 23 Mar 2004 |
SIG ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Sigma Healthcare Ltd
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.
SIG Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
06 Dec 2023 | $0.77 | $0.02 | 2.68% | 338,340 | $0.75 | $0.77 | $0.74 |
05 Dec 2023 | $0.75 | $0.02 | 2.74% | 911,711 | $0.74 | $0.75 | $0.72 |
04 Dec 2023 | $0.73 | $0.02 | 2.80% | 935,506 | $0.71 | $0.75 | $0.71 |
01 Dec 2023 | $0.72 | $0.02 | 2.86% | 6,307,627 | $0.71 | $0.72 | $0.69 |
30 Nov 2023 | $0.70 | $-0.02 | -2.80% | 1,629,258 | $0.71 | $0.71 | $0.68 |
29 Nov 2023 | $0.72 | $0.02 | 2.88% | 528,546 | $0.70 | $0.72 | $0.70 |
28 Nov 2023 | $0.70 | $-0.01 | -1.43% | 1,973,053 | $0.71 | $0.71 | $0.69 |
27 Nov 2023 | $0.70 | $0.00 | 0.00% | 638,656 | $0.70 | $0.71 | $0.70 |
24 Nov 2023 | $0.70 | $0.01 | 1.45% | 232,563 | $0.70 | $0.70 | $0.69 |
23 Nov 2023 | $0.69 | $-0.01 | -1.43% | 935,828 | $0.69 | $0.69 | $0.68 |
22 Nov 2023 | $0.70 | $-0.01 | -1.42% | 716,053 | $0.71 | $0.72 | $0.69 |
21 Nov 2023 | $0.71 | $-0.01 | -1.41% | 696,489 | $0.71 | $0.71 | $0.70 |
20 Nov 2023 | $0.71 | $0.01 | 1.42% | 903,829 | $0.71 | $0.72 | $0.71 |
17 Nov 2023 | $0.71 | $-0.02 | -2.78% | 409,595 | $0.72 | $0.72 | $0.71 |
16 Nov 2023 | $0.72 | $0.01 | 1.41% | 1,445,095 | $0.72 | $0.73 | $0.70 |
15 Nov 2023 | $0.71 | $0.01 | 1.43% | 732,914 | $0.70 | $0.72 | $0.70 |
14 Nov 2023 | $0.70 | $-0.01 | -1.41% | 496,695 | $0.72 | $0.72 | $0.70 |
13 Nov 2023 | $0.71 | $-0.01 | -1.40% | 692,546 | $0.72 | $0.72 | $0.70 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
10 Jul 2023 | Neville Mitchell | Buy | 5,490 | $4,461 |
Directors' share plan.
|
10 Jul 2023 | Kathryn (Kate) Spargo | Buy | 7,116 | $5,782 |
Directors' share plan.
|
10 Jul 2023 | Christine Bartlett | Buy | 6,506 | $5,286 |
Directors' share plan.
|
10 Jul 2023 | Michael Sammells | Buy | 11,792 | $9,582 |
Directors' share plan.
|
10 Jul 2023 | Annette Carey | Buy | 5,489 | $4,460 |
Directors' share plan.
|
13 Jun 2023 | Vikesh Ramsunder | Issued | 3,112,283 | $2,614,317 |
Issue of securities. 63,17,590 Rights
|
18 Apr 2023 | Vikesh Ramsunder | Issued | 240,462 | $170,728 |
Issue of securities. 32,05,307 rights
|
18 Apr 2023 | Christine Bartlett | Buy | 7,446 | $5,286 |
Directors' share plan.
|
18 Apr 2023 | Michael Sammells | Buy | 13,496 | $9,582 |
Directors' share plan.
|
18 Apr 2023 | David Manuel | Buy | 6,981 | $4,956 |
Directors' share plan.
|
18 Apr 2023 | Neville Mitchell | Buy | 4,091 | $2,904 |
Directors' share plan.
|
18 Apr 2023 | Kathryn (Kate) Spargo | Buy | 8,144 | $5,782 |
Directors' share plan.
|
20 Dec 2022 | Kathryn (Kate) Spargo | Buy | 9,506 | $5,846 |
Directors' share plan.
|
20 Dec 2022 | Christine Bartlett | Buy | 8,596 | $5,286 |
Directors' share plan.
|
20 Dec 2022 | David Manuel | Buy | 8,059 | $4,956 |
Directors' share plan.
|
20 Dec 2022 | Michael Sammells | Buy | 15,581 | $9,582 |
Directors' share plan.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Dr Christopher Graham Roberts | Non-Executive Director | Oct 2023 |
Dr Roberts has more than 40 years experience in the medical device industry, including as the former CEO of Cochlear Limited (ASX:COH) from 2004 to 2015, Executive Vice President of ResMed Inc (NYSE:RMD) from 1992 to 2003 and as a Director until November 2017. He is currently a Non-Executive Director of: HMC Capital managed HealthCo Healthcare and Wellness REIT (ASX: HCW), HMC Capital Partners Fund 1, Clarity Pharmaceuticals Limited (ASX:CU6), Nutromics Pty Ltd, Atmo Biosciences Limited and the Cochlear Foundation Board. He is also a Governor of the Centenary Institute Cancer Medicine and Cell Biology.
|
Mr Neville Mitchell | Non-Executive Director | Feb 2023 |
Mr Mitchell has financial experience coupled with more than a decade of experience as an active Nonexecutive Director. He is a current Director and Chair of the Audit Committee of Sonic Healthcare and is a Director and Chair of the Audit and Risk Committee of Fisher and Paykel Healthcare and QBiotics. Previously, Mr Mitchell has held other Director roles including South Eastern Sydney Local Health District, The Board of Taxation, Sirtex Medical and Osprey Medical Inc. Prior to becoming a Non-Executive Director, Mr Mitchell had a career spanning 27 years with Cochlear Limited, 22 of those years as Chief Financial Officer and Company Secretary.
|
Ms Kathryn (Kate) Dianne Spargo | Non-Executive Director | Dec 2015 |
Ms Spargo has gained business experience as both an adviser, having worked in private practice and government, and as a director of listed and unlisted companies. Ms Spargo is currently Non-Executive Director at Sonic Healthcare Limited, Adairs Limited, and CIMIC Ltd. Ms Spargo has held as Non-Executive Director in Xenith IP Ltd and Fletcher Building Limited. In addition, Ms Spargo's current positions in unlisted companies include Chairman of CoInvest and Director at the Geelong Football Club and Future Fuels Cooperative Research Centre. She is a Member of Risk Management and People committee.
|
Mr Michael Sammells | Non-Executive DirectorInterim Chairman | Feb 2020 |
Mr Sammells is currently a NonExecutive Director at AMP. Mr Sammells has 35 years of experience in finance, corporate services, and has held operational roles with expertise in finance, accounting, treasury, investor relations, capital developments, mergers and acquisitions and IPOs. Mr Sammells is a former Chief Financial Officer of Healthscope Limited and Medibank Private. He is a Chair of Risk Management Committee.
|
Mr Vikesh Ramsunder | Chief Executive OfficerManaging Director | Feb 2022 |
Mr Ramsunder was previously Group CEO of Clicks Group in South Africa, a position he held since January 2019. Prior to becoming Group CEO, Vikesh held a number of roles within the Clicks Group, including Chief Operating Officer from 2015, and Managing Director of United Pharmaceutical Distributors (UPD), the Click Group's pharmaceutical wholesale and distribution division.
|
Ms Annette May Carey | Non-Executive Director | Apr 2023 |
Ms Carey is a current Director of National Intermodal Corporation and an Advisory Board Member of Orizontas. Prior to that, Ms Carey has been a Director of Linfox Armaguard Pty Ltd and Sai Cheng Logistics Inc and was Chair of Australia Post Global and BevChain. Ms Carey brings a technical as well as strategic and commercial intellect from over 20 years experience in transport, supply chain and logistics. Ms Carey has previously held various senior roles within Linfox, progressing from General Counsel and Company Secretary to Chief Executive Officer. Ms Carey also held the position of Executive General Manager International with Australia Post.
|
Ms Kara McGowan | General CounselCompany Secretary | Oct 2021 |
-
|
Kara McGowan | General CounselCompany Secretary |
-
|
|
Kara McGowan | General Counsel & Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Hmc Capital Partners Holdings Pty Ltd | 202,034,368 | 19.07% |
Citicorp Nominees Pty Limited | 182,778,084 | 17.25% |
Hsbc Custody Nominees (Australia) Limited | 118,845,999 | 11.22% |
J P Morgan Nominees Australia Pty Limited | 83,059,531 | 7.84% |
Pacific Custodians Pty Limited | 35,188,143 | 3.32% |
Sigma Employee Share Admin P/L | 33,222,595 | 3.14% |
Ubs Nominees Pty Ltd | 28,607,742 | 2.70% |
Hsbc Custody Nominees (Australia) Limited Nt- Comnwlth Super Corp | 17,579,895 | 1.66% |
National Nominees Limited | 17,135,773 | 1.62% |
Hsbc Custody Nominees (Australia) Limited A/C 2 | 9,811,532 | 0.93% |
Bnp Paribas Noms Pty Ltd | 9,271,084 | 0.88% |
Mr Mark Robert Hooper | 8,990,863 | 0.85% |
Invia Custodian Pty Limited | 7,596,480 | 0.72% |
Bnp Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd | 5,300,285 | 0.50% |
De Fazio Capital Pty Ltd | 5,000,000 | 0.47% |
Netwealth Investments Limited | 3,223,629 | 0.30% |
Citicorp Nominees Pty Limited i | 2,609,335 | 0.25% |
Alphagen Capital Pty Ltd | 2,500,000 | 0.24% |
Mr Jeffrey Sells | 2,400,021 | 0.23% |
Bnp Paribas Nominees Pty Ltd Acf Clearstream | 2,280,888 | 0.22% |